it's time to live in a world with less pain.

Check out CerSci in the press right here!

The mission of CerSci Therapeutics is singular- pain relief from new drugs developed from understanding mechanisms which cause pain, and conquering resultant neuronal sensitization.  This mandate sets CerSci apart from other companies with analgesic products / programs.  Our research is supported by robust scientific data and backed by a team with synergistic expertise.  Our first drug will go into human clinical trials in 2018, we expect to receive FDA high-priority status and we will provide an efficacy readout in late 2018.